跳至主要内容
临床试验/NCT01560702
NCT01560702已完成不适用

Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers

Zagazig University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
hemostasis from the ulcer after injection and/or stoppage of haematemesis and melena one day after the procedure.

研究概览

简要总结

Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.

详细描述

To test the hypothesis that endoscopic injection of autologous blood is superior to endoscopic injection of diluted epinephrine in controlling bleeding from gastroduodenal ulcers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • all adult patients with gastroduodenal ulcer

排除标准

  • Patients with non ulcer bleeding.
  • Patients with malignancy.
  • Patients with bleeding disorders or under coagulation therapy.
  • Patients with known allergy to epinephrine.

研究组 & 干预措施

Autologous blood

Active Comparator

Patients will be injected by autologous blood at the edge of actively bleeding ulcer

干预措施: Blood (Biological)

Epinephrine injection

Other

Patients will be injected by diluted epinephrine at the edge of actively bleeding ulcer

干预措施: Epinephrine (Drug)

结局指标

主要结局

hemostasis from the ulcer after injection and/or stoppage of haematemesis and melena one day after the procedure.

时间窗: 12 months

次要结局

  • development of re-bleeding after 24 hours after the procedure (occurrence of hematemesis or melena or drop of hemoglobin level >2gm/dl).(12 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Moahmed Hassan Emara

Lecturer

Zagazig University

研究点 (1)

Loading locations...

相似试验